4 news items
HC Wainwright & Co. Reiterates Buy on Akero Therapeutics, Maintains $50 Price Target
AKRO
11 Jun 24
HC Wainwright & Co. analyst Ed Arce reiterates Akero Therapeutics (NASDAQ:AKRO) with a Buy and maintains $50 price target.
Evercore ISI Group Maintains Outperform on Akero Therapeutics, Lowers Price Target to $38
AKRO
15 May 24
Evercore ISI Group analyst Liisa Bayko maintains Akero Therapeutics (NASDAQ:AKRO) with a Outperform and lowers the price target from $50 to $38.
Canaccord Genuity Maintains Buy on Akero Therapeutics, Lowers Price Target to $56
AKRO
13 May 24
Canaccord Genuity analyst Edward Nash maintains Akero Therapeutics (NASDAQ:AKRO) with a Buy and lowers the price target from $59 to $56.
HC Wainwright & Co. Reiterates Buy on Akero Therapeutics, Maintains $50 Price Target
AKRO
13 May 24
HC Wainwright & Co. analyst Ed Arce reiterates Akero Therapeutics (NASDAQ:AKRO) with a Buy and maintains $50 price target.
- Prev
- 1
- Next